40
Participants
Start Date
August 1, 2007
Primary Completion Date
April 17, 2008
Study Completion Date
April 17, 2008
GSK716155 for injection
GSK716155 will be available with doses of 15 milligrams once a week, 30 milligrams once a week, 50 milligrams biweekly or 100 milligrams once every four weeks.
Placebo
Subjects will also receive placebo.
GSK Investigational Site, Fukuoka
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
Lead Sponsor
GlaxoSmithKline
INDUSTRY